David Deichler
Investor Relations
Replay available
BillionToOne, Inc. (NASDAQ: BLLN) Q4 2025 earnings conference call, held 2026-03-04. Replay captured from the company's public earnings webcast.

Investor Relations
Co-founder & Chief Executive Officer
Chief Financial Officer
Analyst, William Blair
Analyst, Stifel
Analyst, BTIG
Analyst, Guggenheim
Analyst, Piper Sandler
Watch the replay and follow the connected company analysis, news, and investor updates for Billiontoone, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.196 Thank you for standing by, and welcome to Billion to One's fourth quarter 00:00:05.196 -- 00:00:09.340 and four-year 2025 earnings conference call. 00:00:09.340 -- 00:00:13.684 At this time, all participants are in a listen-only mode. 00:00:13.684 -- 00:00:18.329 After the speaker presentation, there will be a question and answer session. 00:00:18.329 -- 00:00:24.275 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:24.275 -- 00:00:28.786 To remove yourself from the queue, you may press star 11 again. 00:00:28.786 -- 00:00:32.990 I would now like to hand the call over to David Deichler, Investor Relations. 00:00:32.990 -- 00:00:35.651 Please go ahead. 00:00:37.174 -- 00:00:40.437 Good afternoon, everyone. Thank you for participating in today's conference call. 00:00:40.437 -- 00:00:44.261 Joining me on the call from Billion to One, we have Ozan Atay, co-founder and chief executive 00:00:44.261 -- 00:00:47.223 officer, and Ross Taylor, chief financial officer. 00:00:47.223 -- 00:00:50.987 Earlier today, Billion to One released financial results for the fourth quarter and full 00:00:50.987 -- 00:00:55.932 year ended December 31st, 2025. A copy of the press release is available on the company's 00:00:55.932 -- 00:01:00.293 website. Before we begin, I want to remind you that during this call, we may make forward-looking 00:01:00.293 -- 00:01:02.976 statements within the meaning of federal securities laws. 00:01:02.976 -- 00:01:06.440 Such statements about future events may include statements about our financial outlook 00:01:06.440 -- 00:01:11.466 and performance, market size, our products and services, reimbursement coverage, future 00:01:11.466 -- 00:01:14.390 clinical performance, and othe...